Why You May Have Gained Weight on Mounjaro

What the SURMOUNT data actually shows about early-phase weight changes

The SURMOUNT-1 trial enrolled 2,539 adults with obesity and tracked them for 72 weeks. Most of the weight loss occurred progressively as doses were titrated upward, not at the very start. Some participants experienced a brief plateau or even a small gain during the earliest weeks before appetite suppression became noticeable. That pattern is biologically predictable: the 2.5 mg starting dose prioritises tolerability over effect. Your digestive system is adjusting to a new hormonal signal, and the metabolic shift that drives fat loss builds over subsequent dose steps.

If you are in your first four to eight weeks and the scales have moved the wrong way, that is not evidence the medicine is failing. It is often evidence the medicine has not yet reached a dose where it works for you personally. A prescriber reviewing your progress can tell the difference between normal early variation and something that needs attention. You can read more about how Mounjaro works and what to expect across the treatment period.

Scales also capture water retention, digestive contents and muscle mass, not just fat. A 1–2 kg upward swing on a given day rarely reflects actual fat gain. Weighing yourself at the same time each week, rather than daily, gives a far more reliable signal.

Specific triggers for gaining weight on Mounjaro worth investigating

Beyond the titration curve, several concrete factors can push weight upward even while taking tirzepatide. If you are trying to understand what is behind gaining weight on Mounjaro, stress and poor sleep are two of the most commonly overlooked culprits, since both raise cortisol, which drives appetite and fat storage independently of the medicine's appetite-suppressing effect. Alcohol, which is calorie-dense and disrupts sleep quality, is another factor our prescribers hear about regularly.

Some medications genuinely counteract tirzepatide's effect. Corticosteroids are the most common culprit, even a short course of prednisolone for an infection can cause rapid fluid and fat accumulation. Certain antidepressants, antipsychotics and mood stabilisers carry weight-gain profiles that can outpace the medicine. If your other prescriptions have changed recently, that is worth flagging. For one specific example, you can see how combining Mounjaro with other medicines can have effects worth reviewing with a clinician.

Hypothyroidism (underactive thyroid) is also worth ruling out if weight gain persists despite an appropriate dose. It is common, often under-recognised, and straightforward to test for via a blood test. A prescriber can refer you for this or liaise with your GP.

When weight gain after a period of loss signals a dose or adherence issue

Some people lose weight well at 5 mg or 7.5 mg, reach a plateau, and then regain a little. This can reflect the body adapting its metabolic rate, a well-documented response to sustained energy deficit, described in NHS guidance on tirzepatide and seen in the SURMOUNT programme. The prescriber's job at this point is to consider whether a higher dose is appropriate, and that decision depends on tolerability, how long you have been at the current dose, and your overall clinical picture.

Inconsistent injection timing matters too. Missing a dose, or injecting significantly later than usual, briefly reduces the medicine's concentration in your system. It is not dangerous, but it can be enough to let appetite rebound for a few days. Our detailed guide to weight gain on Mounjaro covers the timing and dose factors most likely to be relevant, and that guidance is the right reference for the specifics.

If you are considering the cost of continuing treatment and whether adjusting your plan makes sense, understanding what drives Mounjaro pricing in the UK private market may help you weigh up the options. The short version: price should follow clinical appropriateness, not the other way around.

What to do if the scales keep rising

A week of unexpected gain is worth noting. If you have been asking why you have gained weight on Mounjaro after three or four weeks of consistent gain despite correct administration, stable other medicines and no obvious lifestyle change, it is worth acting on by telling your prescriber. At nume, that means contacting our clinical team (contact details are on the support page) who can review your progress notes and advise on next steps without you needing to start the process from scratch.

The broader picture matters here. Tirzepatide is one part of a treatment plan that also involves nutrition, activity and sleep. No dose adjustment fully compensates for a major change in any of those. The NHS England guidance on weight-management injections is explicit that these medicines work alongside lifestyle changes, not instead of them.

If you are not currently on treatment and are trying to understand whether tirzepatide is suitable for you after a previous experience elsewhere, starting a free consultation with our prescribers is the right next step. A real clinician, not automated software, reads every submission the same day and can give you a considered view of what happened and what might work differently.